Private Equity & Venture Capital

Making investments in a constantly shifting market environment calls for keen instincts and negotiation skills honed by years of experience. We will provide you with well-considered and practical solutions for every phase of your investment.

Our services cover the full range of business law. Your projects will benefit from, among other things, top-tier finance, incentive scheme and structuring solutions custom tailored for PE&VC transactions.


The versatile expertise of our dedicated private equity specialists ensures that we will carry out your project efficiently and cost-effectively. We understand your business and your goals – and focus on what really matters.

References

Aura Capital and other sellers: sale of Bluegiga Technologies, one of the fastest growing independent providers of short-range wireless connectivity solutions and software for the IoT, to Silicon Labs (NASDAQ: SLAB).

CapMan Plc: We advised funds managed by CapMan and other shareholders in the sale of the Finnish home textile manufacturer Finlayson & Co Oy, and we advised Finlayson & Co Oy in the simultaneous sale of Familon duvets and mattresses to Trading House Eesti.

Finnish Industry Investment: acquisition of Meyer Turku, the international shipbuilding company specialized in technologically demanding shipbuilding projects, including the M/S Oasis of the Seas and the M/S Allure of the Seas, Finland’s largest export products and the world’s largest and most innovative cruise ships.

Index Ventures and the investor syndicate (Index Ventures, Institutional Venture Partners and Atomico) led by Index Ventures: investment in the Finnish Gaming Company Supercell Oy. In the transaction, Index Ventures, IVP and Atomico purchased 16.7% of the shares in Supercell. Supercell is known for their top grossing games Clash of Clans and Hay Day.

Verdane Capital and other sellers: Finnish counsel in the sale of CRF Box (CRF Health), the leading provider of electronic Clinical Outcome Assessment (eCOA) solutions for global clinical trials, to funds managed and advised by Vitruvian Partners.